Review
doi: 10.1007/BF00254978.
Chemotherapy in the management of invasive bladder cancer. A review
- PMID: 389480
- DOI: 10.1007/BF00254978
Item in Clipboard
Review
Chemotherapy in the management of invasive bladder cancer. A review
Cancer Chemother Pharmacol.
1979.
Abstract
In this review of the management of invasive carcinoma of the bladder the results of primary and systemic therapies are evaluated in the light of the natural history of the disease. The clinical and pathological causes of treatment failure are assessed in an attempt to identify new approaches that may be used in the future management of patients with bladder cancer. To improve survival in this disease requires different approaches to both the control of local disease and the early control of metastatic disease.
Similar articles
-
Systemic therapy of bladder cancer.Prog Clin Biol Res. 1984;162B:95-105. Prog Clin Biol Res. 1984. PMID: 6209726 Review. No abstract available.
-
[Chemotherapy of bladder tumors].Lille Med. 1978 Aug-Sep;23(7):486-9. Lille Med. 1978. PMID: 364222 Review. French. No abstract available.
-
The chemotherapy of bladder carcinoma: systemic therapy.Recent Results Cancer Res. 1983;85:37-49. doi: 10.1007/978-3-642-81994-0_3. Recent Results Cancer Res. 1983. PMID: 6408717 Review. No abstract available.
-
The chemotherapy of advanced bladder carcinoma.Cancer Res. 1977 Aug;37(8 Pt 2):2771-4. Cancer Res. 1977. PMID: 326391 Review.
-
Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: a 5-year followup.J Urol. 1994 Mar;151(3):593-7. doi: 10.1016/s0022-5347(17)35024-3. J Urol. 1994. PMID: 8308965 Clinical Trial.
Cited by
-
Therapeutic Targeting of DNA Replication Stress in Cancer.Genes (Basel). 2023 Jun 26;14(7):1346. doi: 10.3390/genes14071346. Genes (Basel). 2023. PMID: 37510250 Free PMC article. Review.